Dr Callum Livingstone
Dr Livingstone was appointed as Consultant Chemical Pathologist/Senior Lecturer in 2001. He is deputy director of Guildford Peptide Hormones Supraregional Assay Service (SAS) located in the Clinical Laboratory, Royal Surrey County Hospital. Clinical interests include lipidology and clinical nutrition.
Specialist Registrar in Chemical PathologyNewcastle-upon-Tyne University Hospitals NHS Trust.April 1996-April 2001.
MRC post-doctoral researcherGlucose Transport Group, Biochemistry Department, Glasgow University.April 1993-April 1996.
PhD studentMolecular Pharmacology Group, Biochemistry Department, Glasgow University.October 1989-April 1993.Thesis title: 'Interactions between insulin and adenlyl cylase signalling.'
SHO in PathologyRoyal Gwent Hospital, Newport.February 1989-August 1989.(Duties in Clinical Haematology, Clinical Biochemistry and Histopathology)
SHO in MedicineRoyal Gwent Hospital, Newport.August 1988-February 1989.(3 months General Medicine/Cardiology and 3 months Geriatric Medicine)
JHO in General MedicineCrosshouse Hospital, Kilmarnock.February 1988-August 1988.
JHO in General SurgeryCrosshouse Hospital, Kilmarnock.August 1987-February 1988.
Insulin resistance, insulin-like growth factors and clinical nutrition.
Module organiser, HCSMOO8, MSc Health and Clinical SciencesModule organiser, BMSM010, MSc Nutritional MedicineChairman of Board of Studies, MSc Health and Clinical Sciences
Livingstone C. Insulin-like growth factor-I and clinical nutrition. Clin Sci 2013; 125: 265-280.
Livingstone C. IGF2 and cancer. Endo Rel Canc 2013; 20: R321-R339
Livingstone C, Borai A. IGF-II: its role in physiology and metabolic disease. Clin Endocrinol 2014; 80: 773-781.
Walsh J, Karanjia ND, Taylor A, Livingstone C. Selenium status in patients receiving short term parenteral nutrition: frequency of deficiency and response to a standard supplementation regimen. ISRN Pathology 2013 http://dx.doi.org/10.1155/2013/604954
Borai A, Livingstone C, Heald AH, Ferns G. Delta insulin-like growth factor binding protein-1 (IGFBP-1): A measure of hepatic insulin resistance? Ann Clin Biochem 2013; 51: 269-276.
Borai A, Bahijri S, Livingstone C, Nawajka, Bawazeer A, Baarmah Z, Shanaa A, Kadam I, Abdelaal M, Assessment of the use of Becton Dickinson plain and serum separator tubes in measurement of 25-hydroxyvitamin D3 (25OHD3) by HPLC and immunoassay methods. J Clin Lab Anal 2014
Conference papersHamilton J, Wark G, Livingstone C. An investigation into the clinical utility of serum IGF-I and IGFBP-3 measurement in adult patients receiving parenteral nutrition.EuroLabFocus, Liverpool, Oct 2014.